Natural Product-Derived Treatments of Neurological and Neuropsychiatric Disorders
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 31 March 2026 | Viewed by 70
Special Issue Editors
Interests: addiction; drug abuse; toxicology; bioactive compound; neurobehavioral
Special Issues, Collections and Topics in MDPI journals
Interests: neuroinflammation; neuropharmacology; pain; bioactive compounds
Special Issues, Collections and Topics in MDPI journals
Interests: bioactive compounds; essential oil; phytochemistry; natural food
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mental health has been a challenge for Public Health systems all over the world. According to the World Health Organization report (2022), an epidemiological study affirms that 970 million people have some type of psychiatric disorder all over the world in 2019, with an estimated substantial increment after 2020, elicited by COVID-19 pandemic as expected. In addition, neurological conditions, i.e., neurodegenerative disorders, have increased in all countries. Consequently, the cost of mental or neurological disorder treatments has increased globally. Unfortunately, ineffectiveness and low adherence characterize psychiatric and neurological therapeutics. Considering the multifactorial etiology of neurological conditions, novel approaches have been proposed, particularly phytomedicine. Bioactive compounds emerge as a valuable source for the several brain affections, including depression, anxiety, cognitive abnormalities, epilepsy, among others. The discovery of targets involved in the neuropharmacological effects to mitigate such neurological disturbances are fundamental in the development of new agents in the therapeutics.
This Special Issue aims to gather original articles or reviews from experts in natural products and bioactive compounds with central nervous system activities, focusing on the neuropharmacological context, to provide potential therapeutics to treat neurological conditions and psychiatric disorders.
Dr. Cristiane S. F. Maia
Dr. Enéas A. Fontes-Júnior
Dr. Mozaniel Santana de Oliveira
Dr. Jofre J. S. Freitas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- bioactive compounds
- neurological conditions
- psychiatric disorders
- phytomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
